ORTHOReBIRTH USA receives FDA clearance for ReBOSSIS: 5 highlights

Biologics

The FDA cleared ORTHOReBIRTH USA's ReBOSSIS. ORTHOReBIRTH develops orthopedic biologics.

Here are five highlights:

 

1. ReBOSSIS is the sole biosynthetic bone scaffold with electrospun microfiber construction.

 

2. The product is designed for posterolateral spine procedures.

 

3. ReBOSSIS has yielded a 54 percent compression recovery rate.

 

4. Providers have used ReBOSSIS in more than 1,500 procedures.

 

5. ORTHOReBIRTH USA is a wholly owned subsidiary of ORTHOReBIRTH Co.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers